Global Dotinurad Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Dotinurad Tablets market size was valued at US$ 74.08 million in 2025 and is forecast to a readjusted size of US$ 191 million by 2032 with a CAGR of 14.6% during review period.
Dotinurad tablets belong to a class of medications known as selective uric acid reabsorption inhibitors.They are primarily prescribed for the treatment of hyperuricemia associated with gout.By blocking URAT1,Dotinurad increases the excretion of uric acid in the urine,thereby lowering blood uric acid levels and reducing the risk of urate crystal formation in joints and tissues.
Dotinurad is a first-in-class Selective Urate Reabsorption Inhibitor (SURI) that lowers serum uric acid levels by selectively inhibiting the URAT1 transporter in the renal proximal tubule, enhancing uric acid excretion. Developed by Eisai, it was first approved in Japan in 2020 and subsequently received marketing authorization in China in December 2024 under the brand name Urelice®. Compared to xanthine oxidase inhibitors like allopurinol and febuxostat, Dotinurad offers a differentiated safety and efficacy profile, particularly in patients with renal dysfunction or intolerance to XOIs. With over 10 million gout patients in China and limited treatment penetration, Dotinurad addresses a significant unmet clinical need. Its novel mechanism, favorable tolerability, and strategic positioning as the first SURI approved in China highlight its strong commercial potential and licensing value in the evolving urate-lowering therapy landscape.
This report is a detailed and comprehensive analysis for global Dotinurad Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Global Dotinurad Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Dotinurad Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Dotinurad Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Chapter 2, to profile the top manufacturers of Dotinurad Tablets, with price, sales quantity, revenue, and global market share of Dotinurad Tablets from 2021 to 2026.
Chapter 3, the Dotinurad Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dotinurad Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Dotinurad Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Dotinurad Tablets.
Chapter 14 and 15, to describe Dotinurad Tablets sales channel, distributors, customers, research findings and conclusion.
Dotinurad tablets belong to a class of medications known as selective uric acid reabsorption inhibitors.They are primarily prescribed for the treatment of hyperuricemia associated with gout.By blocking URAT1,Dotinurad increases the excretion of uric acid in the urine,thereby lowering blood uric acid levels and reducing the risk of urate crystal formation in joints and tissues.
Dotinurad is a first-in-class Selective Urate Reabsorption Inhibitor (SURI) that lowers serum uric acid levels by selectively inhibiting the URAT1 transporter in the renal proximal tubule, enhancing uric acid excretion. Developed by Eisai, it was first approved in Japan in 2020 and subsequently received marketing authorization in China in December 2024 under the brand name Urelice®. Compared to xanthine oxidase inhibitors like allopurinol and febuxostat, Dotinurad offers a differentiated safety and efficacy profile, particularly in patients with renal dysfunction or intolerance to XOIs. With over 10 million gout patients in China and limited treatment penetration, Dotinurad addresses a significant unmet clinical need. Its novel mechanism, favorable tolerability, and strategic positioning as the first SURI approved in China highlight its strong commercial potential and licensing value in the evolving urate-lowering therapy landscape.
This report is a detailed and comprehensive analysis for global Dotinurad Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Dotinurad Tablets market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032Global Dotinurad Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Dotinurad Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Dotinurad Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Dotinurad Tablets
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Dotinurad Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.Market segment by Type
- 0.5mg per Tablet
- 1.0mg per Tablet
- 2.0mg per Tablet
Market segment by Technology
- Original Drug
- Generic Drug
Market segment by Application
- Hyperuricaemia
- Gout
- Other
Major players covered
- Fuji Yakuhin
- Mochida Pharmaceutical
- Eisai
- Ziska Pharmaceutical
- General Pharmaceuticals
Market segment by region, regional analysis covers
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dotinurad Tablets product scope, market overview, market estimation caveats and base year.Chapter 2, to profile the top manufacturers of Dotinurad Tablets, with price, sales quantity, revenue, and global market share of Dotinurad Tablets from 2021 to 2026.
Chapter 3, the Dotinurad Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dotinurad Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Dotinurad Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Dotinurad Tablets.
Chapter 14 and 15, to describe Dotinurad Tablets sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Dotinurad Tablets Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 0.5mg per Tablet
1.3.3 1.0mg per Tablet
1.3.4 2.0mg per Tablet
1.4 Market Analysis by Technology
1.4.1 Overview: Global Dotinurad Tablets Consumption Value by Technology: 2021 Versus 2025 Versus 2032
1.4.2 Original Drug
1.4.3 Generic Drug
1.5 Market Analysis by Application
1.5.1 Overview: Global Dotinurad Tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.5.2 Hyperuricaemia
1.5.3 Gout
1.5.4 Other
1.6 Global Dotinurad Tablets Market Size & Forecast
1.6.1 Global Dotinurad Tablets Consumption Value (2021 & 2025 & 2032)
1.6.2 Global Dotinurad Tablets Sales Quantity (2021-2032)
1.6.3 Global Dotinurad Tablets Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Fuji Yakuhin
2.1.1 Fuji Yakuhin Details
2.1.2 Fuji Yakuhin Major Business
2.1.3 Fuji Yakuhin Dotinurad Tablets Product and Services
2.1.4 Fuji Yakuhin Dotinurad Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Fuji Yakuhin Recent Developments/Updates
2.2 Mochida Pharmaceutical
2.2.1 Mochida Pharmaceutical Details
2.2.2 Mochida Pharmaceutical Major Business
2.2.3 Mochida Pharmaceutical Dotinurad Tablets Product and Services
2.2.4 Mochida Pharmaceutical Dotinurad Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Mochida Pharmaceutical Recent Developments/Updates
2.3 Eisai
2.3.1 Eisai Details
2.3.2 Eisai Major Business
2.3.3 Eisai Dotinurad Tablets Product and Services
2.3.4 Eisai Dotinurad Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Eisai Recent Developments/Updates
2.4 Ziska Pharmaceutical
2.4.1 Ziska Pharmaceutical Details
2.4.2 Ziska Pharmaceutical Major Business
2.4.3 Ziska Pharmaceutical Dotinurad Tablets Product and Services
2.4.4 Ziska Pharmaceutical Dotinurad Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Ziska Pharmaceutical Recent Developments/Updates
2.5 General Pharmaceuticals
2.5.1 General Pharmaceuticals Details
2.5.2 General Pharmaceuticals Major Business
2.5.3 General Pharmaceuticals Dotinurad Tablets Product and Services
2.5.4 General Pharmaceuticals Dotinurad Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 General Pharmaceuticals Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: DOTINURAD TABLETS BY MANUFACTURER
3.1 Global Dotinurad Tablets Sales Quantity by Manufacturer (2021-2026)
3.2 Global Dotinurad Tablets Revenue by Manufacturer (2021-2026)
3.3 Global Dotinurad Tablets Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Dotinurad Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Dotinurad Tablets Manufacturer Market Share in 2025
3.4.3 Top 6 Dotinurad Tablets Manufacturer Market Share in 2025
3.5 Dotinurad Tablets Market: Overall Company Footprint Analysis
3.5.1 Dotinurad Tablets Market: Region Footprint
3.5.2 Dotinurad Tablets Market: Company Product Type Footprint
3.5.3 Dotinurad Tablets Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Dotinurad Tablets Market Size by Region
4.1.1 Global Dotinurad Tablets Sales Quantity by Region (2021-2032)
4.1.2 Global Dotinurad Tablets Consumption Value by Region (2021-2032)
4.1.3 Global Dotinurad Tablets Average Price by Region (2021-2032)
4.2 North America Dotinurad Tablets Consumption Value (2021-2032)
4.3 Europe Dotinurad Tablets Consumption Value (2021-2032)
4.4 Asia-Pacific Dotinurad Tablets Consumption Value (2021-2032)
4.5 South America Dotinurad Tablets Consumption Value (2021-2032)
4.6 Middle East & Africa Dotinurad Tablets Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Dotinurad Tablets Sales Quantity by Type (2021-2032)
5.2 Global Dotinurad Tablets Consumption Value by Type (2021-2032)
5.3 Global Dotinurad Tablets Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Dotinurad Tablets Sales Quantity by Application (2021-2032)
6.2 Global Dotinurad Tablets Consumption Value by Application (2021-2032)
6.3 Global Dotinurad Tablets Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Dotinurad Tablets Sales Quantity by Type (2021-2032)
7.2 North America Dotinurad Tablets Sales Quantity by Application (2021-2032)
7.3 North America Dotinurad Tablets Market Size by Country
7.3.1 North America Dotinurad Tablets Sales Quantity by Country (2021-2032)
7.3.2 North America Dotinurad Tablets Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Dotinurad Tablets Sales Quantity by Type (2021-2032)
8.2 Europe Dotinurad Tablets Sales Quantity by Application (2021-2032)
8.3 Europe Dotinurad Tablets Market Size by Country
8.3.1 Europe Dotinurad Tablets Sales Quantity by Country (2021-2032)
8.3.2 Europe Dotinurad Tablets Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Dotinurad Tablets Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Dotinurad Tablets Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Dotinurad Tablets Market Size by Region
9.3.1 Asia-Pacific Dotinurad Tablets Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Dotinurad Tablets Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Dotinurad Tablets Sales Quantity by Type (2021-2032)
10.2 South America Dotinurad Tablets Sales Quantity by Application (2021-2032)
10.3 South America Dotinurad Tablets Market Size by Country
10.3.1 South America Dotinurad Tablets Sales Quantity by Country (2021-2032)
10.3.2 South America Dotinurad Tablets Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Dotinurad Tablets Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Dotinurad Tablets Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Dotinurad Tablets Market Size by Country
11.3.1 Middle East & Africa Dotinurad Tablets Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Dotinurad Tablets Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Dotinurad Tablets Market Drivers
12.2 Dotinurad Tablets Market Restraints
12.3 Dotinurad Tablets Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Dotinurad Tablets and Key Manufacturers
13.2 Manufacturing Costs Percentage of Dotinurad Tablets
13.3 Dotinurad Tablets Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Dotinurad Tablets Typical Distributors
14.3 Dotinurad Tablets Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Dotinurad Tablets Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 0.5mg per Tablet
1.3.3 1.0mg per Tablet
1.3.4 2.0mg per Tablet
1.4 Market Analysis by Technology
1.4.1 Overview: Global Dotinurad Tablets Consumption Value by Technology: 2021 Versus 2025 Versus 2032
1.4.2 Original Drug
1.4.3 Generic Drug
1.5 Market Analysis by Application
1.5.1 Overview: Global Dotinurad Tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.5.2 Hyperuricaemia
1.5.3 Gout
1.5.4 Other
1.6 Global Dotinurad Tablets Market Size & Forecast
1.6.1 Global Dotinurad Tablets Consumption Value (2021 & 2025 & 2032)
1.6.2 Global Dotinurad Tablets Sales Quantity (2021-2032)
1.6.3 Global Dotinurad Tablets Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Fuji Yakuhin
2.1.1 Fuji Yakuhin Details
2.1.2 Fuji Yakuhin Major Business
2.1.3 Fuji Yakuhin Dotinurad Tablets Product and Services
2.1.4 Fuji Yakuhin Dotinurad Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Fuji Yakuhin Recent Developments/Updates
2.2 Mochida Pharmaceutical
2.2.1 Mochida Pharmaceutical Details
2.2.2 Mochida Pharmaceutical Major Business
2.2.3 Mochida Pharmaceutical Dotinurad Tablets Product and Services
2.2.4 Mochida Pharmaceutical Dotinurad Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Mochida Pharmaceutical Recent Developments/Updates
2.3 Eisai
2.3.1 Eisai Details
2.3.2 Eisai Major Business
2.3.3 Eisai Dotinurad Tablets Product and Services
2.3.4 Eisai Dotinurad Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Eisai Recent Developments/Updates
2.4 Ziska Pharmaceutical
2.4.1 Ziska Pharmaceutical Details
2.4.2 Ziska Pharmaceutical Major Business
2.4.3 Ziska Pharmaceutical Dotinurad Tablets Product and Services
2.4.4 Ziska Pharmaceutical Dotinurad Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Ziska Pharmaceutical Recent Developments/Updates
2.5 General Pharmaceuticals
2.5.1 General Pharmaceuticals Details
2.5.2 General Pharmaceuticals Major Business
2.5.3 General Pharmaceuticals Dotinurad Tablets Product and Services
2.5.4 General Pharmaceuticals Dotinurad Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 General Pharmaceuticals Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: DOTINURAD TABLETS BY MANUFACTURER
3.1 Global Dotinurad Tablets Sales Quantity by Manufacturer (2021-2026)
3.2 Global Dotinurad Tablets Revenue by Manufacturer (2021-2026)
3.3 Global Dotinurad Tablets Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Dotinurad Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Dotinurad Tablets Manufacturer Market Share in 2025
3.4.3 Top 6 Dotinurad Tablets Manufacturer Market Share in 2025
3.5 Dotinurad Tablets Market: Overall Company Footprint Analysis
3.5.1 Dotinurad Tablets Market: Region Footprint
3.5.2 Dotinurad Tablets Market: Company Product Type Footprint
3.5.3 Dotinurad Tablets Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Dotinurad Tablets Market Size by Region
4.1.1 Global Dotinurad Tablets Sales Quantity by Region (2021-2032)
4.1.2 Global Dotinurad Tablets Consumption Value by Region (2021-2032)
4.1.3 Global Dotinurad Tablets Average Price by Region (2021-2032)
4.2 North America Dotinurad Tablets Consumption Value (2021-2032)
4.3 Europe Dotinurad Tablets Consumption Value (2021-2032)
4.4 Asia-Pacific Dotinurad Tablets Consumption Value (2021-2032)
4.5 South America Dotinurad Tablets Consumption Value (2021-2032)
4.6 Middle East & Africa Dotinurad Tablets Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Dotinurad Tablets Sales Quantity by Type (2021-2032)
5.2 Global Dotinurad Tablets Consumption Value by Type (2021-2032)
5.3 Global Dotinurad Tablets Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Dotinurad Tablets Sales Quantity by Application (2021-2032)
6.2 Global Dotinurad Tablets Consumption Value by Application (2021-2032)
6.3 Global Dotinurad Tablets Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Dotinurad Tablets Sales Quantity by Type (2021-2032)
7.2 North America Dotinurad Tablets Sales Quantity by Application (2021-2032)
7.3 North America Dotinurad Tablets Market Size by Country
7.3.1 North America Dotinurad Tablets Sales Quantity by Country (2021-2032)
7.3.2 North America Dotinurad Tablets Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Dotinurad Tablets Sales Quantity by Type (2021-2032)
8.2 Europe Dotinurad Tablets Sales Quantity by Application (2021-2032)
8.3 Europe Dotinurad Tablets Market Size by Country
8.3.1 Europe Dotinurad Tablets Sales Quantity by Country (2021-2032)
8.3.2 Europe Dotinurad Tablets Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Dotinurad Tablets Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Dotinurad Tablets Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Dotinurad Tablets Market Size by Region
9.3.1 Asia-Pacific Dotinurad Tablets Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Dotinurad Tablets Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Dotinurad Tablets Sales Quantity by Type (2021-2032)
10.2 South America Dotinurad Tablets Sales Quantity by Application (2021-2032)
10.3 South America Dotinurad Tablets Market Size by Country
10.3.1 South America Dotinurad Tablets Sales Quantity by Country (2021-2032)
10.3.2 South America Dotinurad Tablets Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Dotinurad Tablets Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Dotinurad Tablets Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Dotinurad Tablets Market Size by Country
11.3.1 Middle East & Africa Dotinurad Tablets Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Dotinurad Tablets Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Dotinurad Tablets Market Drivers
12.2 Dotinurad Tablets Market Restraints
12.3 Dotinurad Tablets Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Dotinurad Tablets and Key Manufacturers
13.2 Manufacturing Costs Percentage of Dotinurad Tablets
13.3 Dotinurad Tablets Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Dotinurad Tablets Typical Distributors
14.3 Dotinurad Tablets Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Dotinurad Tablets Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Dotinurad Tablets Consumption Value by Technology, (USD Million), 2021 & 2025 & 2032
Table 3. Global Dotinurad Tablets Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 4. Fuji Yakuhin Basic Information, Manufacturing Base and Competitors
Table 5. Fuji Yakuhin Major Business
Table 6. Fuji Yakuhin Dotinurad Tablets Product and Services
Table 7. Fuji Yakuhin Dotinurad Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 8. Fuji Yakuhin Recent Developments/Updates
Table 9. Mochida Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 10. Mochida Pharmaceutical Major Business
Table 11. Mochida Pharmaceutical Dotinurad Tablets Product and Services
Table 12. Mochida Pharmaceutical Dotinurad Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 13. Mochida Pharmaceutical Recent Developments/Updates
Table 14. Eisai Basic Information, Manufacturing Base and Competitors
Table 15. Eisai Major Business
Table 16. Eisai Dotinurad Tablets Product and Services
Table 17. Eisai Dotinurad Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 18. Eisai Recent Developments/Updates
Table 19. Ziska Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 20. Ziska Pharmaceutical Major Business
Table 21. Ziska Pharmaceutical Dotinurad Tablets Product and Services
Table 22. Ziska Pharmaceutical Dotinurad Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. Ziska Pharmaceutical Recent Developments/Updates
Table 24. General Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 25. General Pharmaceuticals Major Business
Table 26. General Pharmaceuticals Dotinurad Tablets Product and Services
Table 27. General Pharmaceuticals Dotinurad Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. General Pharmaceuticals Recent Developments/Updates
Table 29. Global Dotinurad Tablets Sales Quantity by Manufacturer (2021-2026) & (K Units)
Table 30. Global Dotinurad Tablets Revenue by Manufacturer (2021-2026) & (USD Million)
Table 31. Global Dotinurad Tablets Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 32. Market Position of Manufacturers in Dotinurad Tablets, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 33. Head Office and Dotinurad Tablets Production Site of Key Manufacturer
Table 34. Dotinurad Tablets Market: Company Product Type Footprint
Table 35. Dotinurad Tablets Market: Company Product Application Footprint
Table 36. Dotinurad Tablets New Market Entrants and Barriers to Market Entry
Table 37. Dotinurad Tablets Mergers, Acquisition, Agreements, and Collaborations
Table 38. Global Dotinurad Tablets Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 39. Global Dotinurad Tablets Sales Quantity by Region (2021-2026) & (K Units)
Table 40. Global Dotinurad Tablets Sales Quantity by Region (2027-2032) & (K Units)
Table 41. Global Dotinurad Tablets Consumption Value by Region (2021-2026) & (USD Million)
Table 42. Global Dotinurad Tablets Consumption Value by Region (2027-2032) & (USD Million)
Table 43. Global Dotinurad Tablets Average Price by Region (2021-2026) & (US$/Unit)
Table 44. Global Dotinurad Tablets Average Price by Region (2027-2032) & (US$/Unit)
Table 45. Global Dotinurad Tablets Sales Quantity by Type (2021-2026) & (K Units)
Table 46. Global Dotinurad Tablets Sales Quantity by Type (2027-2032) & (K Units)
Table 47. Global Dotinurad Tablets Consumption Value by Type (2021-2026) & (USD Million)
Table 48. Global Dotinurad Tablets Consumption Value by Type (2027-2032) & (USD Million)
Table 49. Global Dotinurad Tablets Average Price by Type (2021-2026) & (US$/Unit)
Table 50. Global Dotinurad Tablets Average Price by Type (2027-2032) & (US$/Unit)
Table 51. Global Dotinurad Tablets Sales Quantity by Application (2021-2026) & (K Units)
Table 52. Global Dotinurad Tablets Sales Quantity by Application (2027-2032) & (K Units)
Table 53. Global Dotinurad Tablets Consumption Value by Application (2021-2026) & (USD Million)
Table 54. Global Dotinurad Tablets Consumption Value by Application (2027-2032) & (USD Million)
Table 55. Global Dotinurad Tablets Average Price by Application (2021-2026) & (US$/Unit)
Table 56. Global Dotinurad Tablets Average Price by Application (2027-2032) & (US$/Unit)
Table 57. North America Dotinurad Tablets Sales Quantity by Type (2021-2026) & (K Units)
Table 58. North America Dotinurad Tablets Sales Quantity by Type (2027-2032) & (K Units)
Table 59. North America Dotinurad Tablets Sales Quantity by Application (2021-2026) & (K Units)
Table 60. North America Dotinurad Tablets Sales Quantity by Application (2027-2032) & (K Units)
Table 61. North America Dotinurad Tablets Sales Quantity by Country (2021-2026) & (K Units)
Table 62. North America Dotinurad Tablets Sales Quantity by Country (2027-2032) & (K Units)
Table 63. North America Dotinurad Tablets Consumption Value by Country (2021-2026) & (USD Million)
Table 64. North America Dotinurad Tablets Consumption Value by Country (2027-2032) & (USD Million)
Table 65. Europe Dotinurad Tablets Sales Quantity by Type (2021-2026) & (K Units)
Table 66. Europe Dotinurad Tablets Sales Quantity by Type (2027-2032) & (K Units)
Table 67. Europe Dotinurad Tablets Sales Quantity by Application (2021-2026) & (K Units)
Table 68. Europe Dotinurad Tablets Sales Quantity by Application (2027-2032) & (K Units)
Table 69. Europe Dotinurad Tablets Sales Quantity by Country (2021-2026) & (K Units)
Table 70. Europe Dotinurad Tablets Sales Quantity by Country (2027-2032) & (K Units)
Table 71. Europe Dotinurad Tablets Consumption Value by Country (2021-2026) & (USD Million)
Table 72. Europe Dotinurad Tablets Consumption Value by Country (2027-2032) & (USD Million)
Table 73. Asia-Pacific Dotinurad Tablets Sales Quantity by Type (2021-2026) & (K Units)
Table 74. Asia-Pacific Dotinurad Tablets Sales Quantity by Type (2027-2032) & (K Units)
Table 75. Asia-Pacific Dotinurad Tablets Sales Quantity by Application (2021-2026) & (K Units)
Table 76. Asia-Pacific Dotinurad Tablets Sales Quantity by Application (2027-2032) & (K Units)
Table 77. Asia-Pacific Dotinurad Tablets Sales Quantity by Region (2021-2026) & (K Units)
Table 78. Asia-Pacific Dotinurad Tablets Sales Quantity by Region (2027-2032) & (K Units)
Table 79. Asia-Pacific Dotinurad Tablets Consumption Value by Region (2021-2026) & (USD Million)
Table 80. Asia-Pacific Dotinurad Tablets Consumption Value by Region (2027-2032) & (USD Million)
Table 81. South America Dotinurad Tablets Sales Quantity by Type (2021-2026) & (K Units)
Table 82. South America Dotinurad Tablets Sales Quantity by Type (2027-2032) & (K Units)
Table 83. South America Dotinurad Tablets Sales Quantity by Application (2021-2026) & (K Units)
Table 84. South America Dotinurad Tablets Sales Quantity by Application (2027-2032) & (K Units)
Table 85. South America Dotinurad Tablets Sales Quantity by Country (2021-2026) & (K Units)
Table 86. South America Dotinurad Tablets Sales Quantity by Country (2027-2032) & (K Units)
Table 87. South America Dotinurad Tablets Consumption Value by Country (2021-2026) & (USD Million)
Table 88. South America Dotinurad Tablets Consumption Value by Country (2027-2032) & (USD Million)
Table 89. Middle East & Africa Dotinurad Tablets Sales Quantity by Type (2021-2026) & (K Units)
Table 90. Middle East & Africa Dotinurad Tablets Sales Quantity by Type (2027-2032) & (K Units)
Table 91. Middle East & Africa Dotinurad Tablets Sales Quantity by Application (2021-2026) & (K Units)
Table 92. Middle East & Africa Dotinurad Tablets Sales Quantity by Application (2027-2032) & (K Units)
Table 93. Middle East & Africa Dotinurad Tablets Sales Quantity by Country (2021-2026) & (K Units)
Table 94. Middle East & Africa Dotinurad Tablets Sales Quantity by Country (2027-2032) & (K Units)
Table 95. Middle East & Africa Dotinurad Tablets Consumption Value by Country (2021-2026) & (USD Million)
Table 96. Middle East & Africa Dotinurad Tablets Consumption Value by Country (2027-2032) & (USD Million)
Table 97. Dotinurad Tablets Raw Material
Table 98. Key Manufacturers of Dotinurad Tablets Raw Materials
Table 99. Dotinurad Tablets Typical Distributors
Table 100. Dotinurad Tablets Typical Customers
Table 1. Global Dotinurad Tablets Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Dotinurad Tablets Consumption Value by Technology, (USD Million), 2021 & 2025 & 2032
Table 3. Global Dotinurad Tablets Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 4. Fuji Yakuhin Basic Information, Manufacturing Base and Competitors
Table 5. Fuji Yakuhin Major Business
Table 6. Fuji Yakuhin Dotinurad Tablets Product and Services
Table 7. Fuji Yakuhin Dotinurad Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 8. Fuji Yakuhin Recent Developments/Updates
Table 9. Mochida Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 10. Mochida Pharmaceutical Major Business
Table 11. Mochida Pharmaceutical Dotinurad Tablets Product and Services
Table 12. Mochida Pharmaceutical Dotinurad Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 13. Mochida Pharmaceutical Recent Developments/Updates
Table 14. Eisai Basic Information, Manufacturing Base and Competitors
Table 15. Eisai Major Business
Table 16. Eisai Dotinurad Tablets Product and Services
Table 17. Eisai Dotinurad Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 18. Eisai Recent Developments/Updates
Table 19. Ziska Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 20. Ziska Pharmaceutical Major Business
Table 21. Ziska Pharmaceutical Dotinurad Tablets Product and Services
Table 22. Ziska Pharmaceutical Dotinurad Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. Ziska Pharmaceutical Recent Developments/Updates
Table 24. General Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 25. General Pharmaceuticals Major Business
Table 26. General Pharmaceuticals Dotinurad Tablets Product and Services
Table 27. General Pharmaceuticals Dotinurad Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. General Pharmaceuticals Recent Developments/Updates
Table 29. Global Dotinurad Tablets Sales Quantity by Manufacturer (2021-2026) & (K Units)
Table 30. Global Dotinurad Tablets Revenue by Manufacturer (2021-2026) & (USD Million)
Table 31. Global Dotinurad Tablets Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 32. Market Position of Manufacturers in Dotinurad Tablets, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 33. Head Office and Dotinurad Tablets Production Site of Key Manufacturer
Table 34. Dotinurad Tablets Market: Company Product Type Footprint
Table 35. Dotinurad Tablets Market: Company Product Application Footprint
Table 36. Dotinurad Tablets New Market Entrants and Barriers to Market Entry
Table 37. Dotinurad Tablets Mergers, Acquisition, Agreements, and Collaborations
Table 38. Global Dotinurad Tablets Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 39. Global Dotinurad Tablets Sales Quantity by Region (2021-2026) & (K Units)
Table 40. Global Dotinurad Tablets Sales Quantity by Region (2027-2032) & (K Units)
Table 41. Global Dotinurad Tablets Consumption Value by Region (2021-2026) & (USD Million)
Table 42. Global Dotinurad Tablets Consumption Value by Region (2027-2032) & (USD Million)
Table 43. Global Dotinurad Tablets Average Price by Region (2021-2026) & (US$/Unit)
Table 44. Global Dotinurad Tablets Average Price by Region (2027-2032) & (US$/Unit)
Table 45. Global Dotinurad Tablets Sales Quantity by Type (2021-2026) & (K Units)
Table 46. Global Dotinurad Tablets Sales Quantity by Type (2027-2032) & (K Units)
Table 47. Global Dotinurad Tablets Consumption Value by Type (2021-2026) & (USD Million)
Table 48. Global Dotinurad Tablets Consumption Value by Type (2027-2032) & (USD Million)
Table 49. Global Dotinurad Tablets Average Price by Type (2021-2026) & (US$/Unit)
Table 50. Global Dotinurad Tablets Average Price by Type (2027-2032) & (US$/Unit)
Table 51. Global Dotinurad Tablets Sales Quantity by Application (2021-2026) & (K Units)
Table 52. Global Dotinurad Tablets Sales Quantity by Application (2027-2032) & (K Units)
Table 53. Global Dotinurad Tablets Consumption Value by Application (2021-2026) & (USD Million)
Table 54. Global Dotinurad Tablets Consumption Value by Application (2027-2032) & (USD Million)
Table 55. Global Dotinurad Tablets Average Price by Application (2021-2026) & (US$/Unit)
Table 56. Global Dotinurad Tablets Average Price by Application (2027-2032) & (US$/Unit)
Table 57. North America Dotinurad Tablets Sales Quantity by Type (2021-2026) & (K Units)
Table 58. North America Dotinurad Tablets Sales Quantity by Type (2027-2032) & (K Units)
Table 59. North America Dotinurad Tablets Sales Quantity by Application (2021-2026) & (K Units)
Table 60. North America Dotinurad Tablets Sales Quantity by Application (2027-2032) & (K Units)
Table 61. North America Dotinurad Tablets Sales Quantity by Country (2021-2026) & (K Units)
Table 62. North America Dotinurad Tablets Sales Quantity by Country (2027-2032) & (K Units)
Table 63. North America Dotinurad Tablets Consumption Value by Country (2021-2026) & (USD Million)
Table 64. North America Dotinurad Tablets Consumption Value by Country (2027-2032) & (USD Million)
Table 65. Europe Dotinurad Tablets Sales Quantity by Type (2021-2026) & (K Units)
Table 66. Europe Dotinurad Tablets Sales Quantity by Type (2027-2032) & (K Units)
Table 67. Europe Dotinurad Tablets Sales Quantity by Application (2021-2026) & (K Units)
Table 68. Europe Dotinurad Tablets Sales Quantity by Application (2027-2032) & (K Units)
Table 69. Europe Dotinurad Tablets Sales Quantity by Country (2021-2026) & (K Units)
Table 70. Europe Dotinurad Tablets Sales Quantity by Country (2027-2032) & (K Units)
Table 71. Europe Dotinurad Tablets Consumption Value by Country (2021-2026) & (USD Million)
Table 72. Europe Dotinurad Tablets Consumption Value by Country (2027-2032) & (USD Million)
Table 73. Asia-Pacific Dotinurad Tablets Sales Quantity by Type (2021-2026) & (K Units)
Table 74. Asia-Pacific Dotinurad Tablets Sales Quantity by Type (2027-2032) & (K Units)
Table 75. Asia-Pacific Dotinurad Tablets Sales Quantity by Application (2021-2026) & (K Units)
Table 76. Asia-Pacific Dotinurad Tablets Sales Quantity by Application (2027-2032) & (K Units)
Table 77. Asia-Pacific Dotinurad Tablets Sales Quantity by Region (2021-2026) & (K Units)
Table 78. Asia-Pacific Dotinurad Tablets Sales Quantity by Region (2027-2032) & (K Units)
Table 79. Asia-Pacific Dotinurad Tablets Consumption Value by Region (2021-2026) & (USD Million)
Table 80. Asia-Pacific Dotinurad Tablets Consumption Value by Region (2027-2032) & (USD Million)
Table 81. South America Dotinurad Tablets Sales Quantity by Type (2021-2026) & (K Units)
Table 82. South America Dotinurad Tablets Sales Quantity by Type (2027-2032) & (K Units)
Table 83. South America Dotinurad Tablets Sales Quantity by Application (2021-2026) & (K Units)
Table 84. South America Dotinurad Tablets Sales Quantity by Application (2027-2032) & (K Units)
Table 85. South America Dotinurad Tablets Sales Quantity by Country (2021-2026) & (K Units)
Table 86. South America Dotinurad Tablets Sales Quantity by Country (2027-2032) & (K Units)
Table 87. South America Dotinurad Tablets Consumption Value by Country (2021-2026) & (USD Million)
Table 88. South America Dotinurad Tablets Consumption Value by Country (2027-2032) & (USD Million)
Table 89. Middle East & Africa Dotinurad Tablets Sales Quantity by Type (2021-2026) & (K Units)
Table 90. Middle East & Africa Dotinurad Tablets Sales Quantity by Type (2027-2032) & (K Units)
Table 91. Middle East & Africa Dotinurad Tablets Sales Quantity by Application (2021-2026) & (K Units)
Table 92. Middle East & Africa Dotinurad Tablets Sales Quantity by Application (2027-2032) & (K Units)
Table 93. Middle East & Africa Dotinurad Tablets Sales Quantity by Country (2021-2026) & (K Units)
Table 94. Middle East & Africa Dotinurad Tablets Sales Quantity by Country (2027-2032) & (K Units)
Table 95. Middle East & Africa Dotinurad Tablets Consumption Value by Country (2021-2026) & (USD Million)
Table 96. Middle East & Africa Dotinurad Tablets Consumption Value by Country (2027-2032) & (USD Million)
Table 97. Dotinurad Tablets Raw Material
Table 98. Key Manufacturers of Dotinurad Tablets Raw Materials
Table 99. Dotinurad Tablets Typical Distributors
Table 100. Dotinurad Tablets Typical Customers
LIST OF FIGURES
Figure 1. Dotinurad Tablets Picture
Figure 2. Global Dotinurad Tablets Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Dotinurad Tablets Revenue Market Share by Type in 2025
Figure 4. 0.5mg per Tablet Examples
Figure 5. 1.0mg per Tablet Examples
Figure 6. 2.0mg per Tablet Examples
Figure 7. Global Dotinurad Tablets Revenue by Technology, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Dotinurad Tablets Revenue Market Share by Technology in 2025
Figure 9. Original Drug Examples
Figure 10. Generic Drug Examples
Figure 11. Global Dotinurad Tablets Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 12. Global Dotinurad Tablets Revenue Market Share by Application in 2025
Figure 13. Hyperuricaemia Examples
Figure 14. Gout Examples
Figure 15. Other Examples
Figure 16. Global Dotinurad Tablets Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 17. Global Dotinurad Tablets Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 18. Global Dotinurad Tablets Sales Quantity (2021-2032) & (K Units)
Figure 19. Global Dotinurad Tablets Price (2021-2032) & (US$/Unit)
Figure 20. Global Dotinurad Tablets Sales Quantity Market Share by Manufacturer in 2025
Figure 21. Global Dotinurad Tablets Revenue Market Share by Manufacturer in 2025
Figure 22. Producer Shipments of Dotinurad Tablets by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 23. Top 3 Dotinurad Tablets Manufacturer (Revenue) Market Share in 2025
Figure 24. Top 6 Dotinurad Tablets Manufacturer (Revenue) Market Share in 2025
Figure 25. Global Dotinurad Tablets Sales Quantity Market Share by Region (2021-2032)
Figure 26. Global Dotinurad Tablets Consumption Value Market Share by Region (2021-2032)
Figure 27. North America Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 28. Europe Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 29. Asia-Pacific Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 30. South America Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 31. Middle East & Africa Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 32. Global Dotinurad Tablets Sales Quantity Market Share by Type (2021-2032)
Figure 33. Global Dotinurad Tablets Consumption Value Market Share by Type (2021-2032)
Figure 34. Global Dotinurad Tablets Average Price by Type (2021-2032) & (US$/Unit)
Figure 35. Global Dotinurad Tablets Sales Quantity Market Share by Application (2021-2032)
Figure 36. Global Dotinurad Tablets Revenue Market Share by Application (2021-2032)
Figure 37. Global Dotinurad Tablets Average Price by Application (2021-2032) & (US$/Unit)
Figure 38. North America Dotinurad Tablets Sales Quantity Market Share by Type (2021-2032)
Figure 39. North America Dotinurad Tablets Sales Quantity Market Share by Application (2021-2032)
Figure 40. North America Dotinurad Tablets Sales Quantity Market Share by Country (2021-2032)
Figure 41. North America Dotinurad Tablets Consumption Value Market Share by Country (2021-2032)
Figure 42. United States Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 43. Canada Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 44. Mexico Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 45. Europe Dotinurad Tablets Sales Quantity Market Share by Type (2021-2032)
Figure 46. Europe Dotinurad Tablets Sales Quantity Market Share by Application (2021-2032)
Figure 47. Europe Dotinurad Tablets Sales Quantity Market Share by Country (2021-2032)
Figure 48. Europe Dotinurad Tablets Consumption Value Market Share by Country (2021-2032)
Figure 49. Germany Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 50. France Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 51. United Kingdom Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 52. Russia Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 53. Italy Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 54. Asia-Pacific Dotinurad Tablets Sales Quantity Market Share by Type (2021-2032)
Figure 55. Asia-Pacific Dotinurad Tablets Sales Quantity Market Share by Application (2021-2032)
Figure 56. Asia-Pacific Dotinurad Tablets Sales Quantity Market Share by Region (2021-2032)
Figure 57. Asia-Pacific Dotinurad Tablets Consumption Value Market Share by Region (2021-2032)
Figure 58. China Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 59. Japan Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 60. South Korea Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 61. India Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 62. Southeast Asia Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 63. Australia Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 64. South America Dotinurad Tablets Sales Quantity Market Share by Type (2021-2032)
Figure 65. South America Dotinurad Tablets Sales Quantity Market Share by Application (2021-2032)
Figure 66. South America Dotinurad Tablets Sales Quantity Market Share by Country (2021-2032)
Figure 67. South America Dotinurad Tablets Consumption Value Market Share by Country (2021-2032)
Figure 68. Brazil Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 69. Argentina Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 70. Middle East & Africa Dotinurad Tablets Sales Quantity Market Share by Type (2021-2032)
Figure 71. Middle East & Africa Dotinurad Tablets Sales Quantity Market Share by Application (2021-2032)
Figure 72. Middle East & Africa Dotinurad Tablets Sales Quantity Market Share by Country (2021-2032)
Figure 73. Middle East & Africa Dotinurad Tablets Consumption Value Market Share by Country (2021-2032)
Figure 74. Turkey Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 75. Egypt Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 76. Saudi Arabia Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 77. South Africa Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 78. Dotinurad Tablets Market Drivers
Figure 79. Dotinurad Tablets Market Restraints
Figure 80. Dotinurad Tablets Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Manufacturing Cost Structure Analysis of Dotinurad Tablets in 2025
Figure 83. Manufacturing Process Analysis of Dotinurad Tablets
Figure 84. Dotinurad Tablets Industrial Chain
Figure 85. Sales Channel: Direct to End-User vs Distributors
Figure 86. Direct Channel Pros & Cons
Figure 87. Indirect Channel Pros & Cons
Figure 88. Methodology
Figure 89. Research Process and Data Source
Figure 1. Dotinurad Tablets Picture
Figure 2. Global Dotinurad Tablets Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Dotinurad Tablets Revenue Market Share by Type in 2025
Figure 4. 0.5mg per Tablet Examples
Figure 5. 1.0mg per Tablet Examples
Figure 6. 2.0mg per Tablet Examples
Figure 7. Global Dotinurad Tablets Revenue by Technology, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Dotinurad Tablets Revenue Market Share by Technology in 2025
Figure 9. Original Drug Examples
Figure 10. Generic Drug Examples
Figure 11. Global Dotinurad Tablets Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 12. Global Dotinurad Tablets Revenue Market Share by Application in 2025
Figure 13. Hyperuricaemia Examples
Figure 14. Gout Examples
Figure 15. Other Examples
Figure 16. Global Dotinurad Tablets Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 17. Global Dotinurad Tablets Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 18. Global Dotinurad Tablets Sales Quantity (2021-2032) & (K Units)
Figure 19. Global Dotinurad Tablets Price (2021-2032) & (US$/Unit)
Figure 20. Global Dotinurad Tablets Sales Quantity Market Share by Manufacturer in 2025
Figure 21. Global Dotinurad Tablets Revenue Market Share by Manufacturer in 2025
Figure 22. Producer Shipments of Dotinurad Tablets by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 23. Top 3 Dotinurad Tablets Manufacturer (Revenue) Market Share in 2025
Figure 24. Top 6 Dotinurad Tablets Manufacturer (Revenue) Market Share in 2025
Figure 25. Global Dotinurad Tablets Sales Quantity Market Share by Region (2021-2032)
Figure 26. Global Dotinurad Tablets Consumption Value Market Share by Region (2021-2032)
Figure 27. North America Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 28. Europe Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 29. Asia-Pacific Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 30. South America Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 31. Middle East & Africa Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 32. Global Dotinurad Tablets Sales Quantity Market Share by Type (2021-2032)
Figure 33. Global Dotinurad Tablets Consumption Value Market Share by Type (2021-2032)
Figure 34. Global Dotinurad Tablets Average Price by Type (2021-2032) & (US$/Unit)
Figure 35. Global Dotinurad Tablets Sales Quantity Market Share by Application (2021-2032)
Figure 36. Global Dotinurad Tablets Revenue Market Share by Application (2021-2032)
Figure 37. Global Dotinurad Tablets Average Price by Application (2021-2032) & (US$/Unit)
Figure 38. North America Dotinurad Tablets Sales Quantity Market Share by Type (2021-2032)
Figure 39. North America Dotinurad Tablets Sales Quantity Market Share by Application (2021-2032)
Figure 40. North America Dotinurad Tablets Sales Quantity Market Share by Country (2021-2032)
Figure 41. North America Dotinurad Tablets Consumption Value Market Share by Country (2021-2032)
Figure 42. United States Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 43. Canada Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 44. Mexico Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 45. Europe Dotinurad Tablets Sales Quantity Market Share by Type (2021-2032)
Figure 46. Europe Dotinurad Tablets Sales Quantity Market Share by Application (2021-2032)
Figure 47. Europe Dotinurad Tablets Sales Quantity Market Share by Country (2021-2032)
Figure 48. Europe Dotinurad Tablets Consumption Value Market Share by Country (2021-2032)
Figure 49. Germany Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 50. France Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 51. United Kingdom Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 52. Russia Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 53. Italy Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 54. Asia-Pacific Dotinurad Tablets Sales Quantity Market Share by Type (2021-2032)
Figure 55. Asia-Pacific Dotinurad Tablets Sales Quantity Market Share by Application (2021-2032)
Figure 56. Asia-Pacific Dotinurad Tablets Sales Quantity Market Share by Region (2021-2032)
Figure 57. Asia-Pacific Dotinurad Tablets Consumption Value Market Share by Region (2021-2032)
Figure 58. China Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 59. Japan Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 60. South Korea Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 61. India Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 62. Southeast Asia Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 63. Australia Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 64. South America Dotinurad Tablets Sales Quantity Market Share by Type (2021-2032)
Figure 65. South America Dotinurad Tablets Sales Quantity Market Share by Application (2021-2032)
Figure 66. South America Dotinurad Tablets Sales Quantity Market Share by Country (2021-2032)
Figure 67. South America Dotinurad Tablets Consumption Value Market Share by Country (2021-2032)
Figure 68. Brazil Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 69. Argentina Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 70. Middle East & Africa Dotinurad Tablets Sales Quantity Market Share by Type (2021-2032)
Figure 71. Middle East & Africa Dotinurad Tablets Sales Quantity Market Share by Application (2021-2032)
Figure 72. Middle East & Africa Dotinurad Tablets Sales Quantity Market Share by Country (2021-2032)
Figure 73. Middle East & Africa Dotinurad Tablets Consumption Value Market Share by Country (2021-2032)
Figure 74. Turkey Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 75. Egypt Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 76. Saudi Arabia Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 77. South Africa Dotinurad Tablets Consumption Value (2021-2032) & (USD Million)
Figure 78. Dotinurad Tablets Market Drivers
Figure 79. Dotinurad Tablets Market Restraints
Figure 80. Dotinurad Tablets Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Manufacturing Cost Structure Analysis of Dotinurad Tablets in 2025
Figure 83. Manufacturing Process Analysis of Dotinurad Tablets
Figure 84. Dotinurad Tablets Industrial Chain
Figure 85. Sales Channel: Direct to End-User vs Distributors
Figure 86. Direct Channel Pros & Cons
Figure 87. Indirect Channel Pros & Cons
Figure 88. Methodology
Figure 89. Research Process and Data Source
